WHO ICTRP trial

Real-World Study of Zishen Yizhi Pill in Treating Cognitive Impairment…

ITMCTR2025000553 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting

Key facts

Trial ID ITMCTR2025000553
Public title Real-World Study of Zishen Yizhi Pill in Treating Cognitive Impairment Associated with Cerebral Small Vessel Disease (Yin Deficiency and Blood Stasis Syndrome)
Scientific title Real-World Study of Zishen Yizhi Pill in Treating Cognitive Impairment Associated with Cerebral Small Vessel Disease (Yin Deficiency and Blood Stasis Syndrome)
Primary sponsor Hunan Provincia Hospital of Integrated Traditional Chinese and Western Medicine ( The Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine)
Registry International Traditional Medicine Clinical Trial Registry (ITMCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase Pilot clinical trial
Countries China
Conditions cognitive impairment of cerebral small vessel disease
Interventions Control group:Guideline-based standardized internal medicine treatment;Treatment Group :Zishen Yizhi Wan
Registration date Mar 20, 2025
Target size Control group:78;Treatment Group :78
Registry page itmctr.ccebtcm.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations